Hovid Montelukast 4mg Tablet

Hovid Montelukast 4mg Tablet is a generic formulation of montelukast, a leukotriene receptor antagonist, at the 4mg strength most commonly prescribed for young children, typically aged 2 to 5 years, for the prevention and long-term control of asthma symptoms and for relief of allergic rhinitis symptoms. It works by blocking leukotrienes, chemical messengers that drive airway inflammation, swelling and mucus production in children with these conditions.

As montelukast is a prescription-only medicine in Malaysia and correct age-appropriate dosing matters greatly in young children, Hovid Montelukast 4mg Tablet is supplied by DoctorOnCall only following an online consultation with a doctor, who will confirm the 4mg strength is appropriate for the child’s age and monitor for any behavioural changes during treatment.

Montelukast selectively blocks cysteinyl leukotriene receptors in the airways, stopping these inflammatory chemicals from causing airway narrowing, swelling of the airway lining and excess mucus production; given once daily, it works as a preventer to keep a young child’s airways calmer over time rather than providing fast relief during a sudden flare-up.

Give Hovid Montelukast 4mg Tablet once daily, generally in the evening, in the form directed for the specific pack (such as a chewable tablet chewed thoroughly before swallowing). It may be given with or without food, and should be continued regularly as prescribed, even during symptom-free periods.

The usual dose for young children, typically aged 2 to 5 years, is one 4mg tablet once daily in the evening, as prescribed by the child’s doctor. Do not use a different strength of montelukast in place of this one without medical advice, and do not double a dose if one is missed.

Hovid Montelukast 4mg Tablet is generally stable for up to 24-36 months from the date of manufacture when stored correctly; always check the expiry date printed on the pack before giving it to a child.

Store below 30°C in a dry place away from direct sunlight and moisture. Keep the tablets in their original packaging and store well out of reach and sight of children.

• Known hypersensitivity to montelukast or any ingredient in the tablet
• Not for treating an acute asthma attack; a fast-acting reliever inhaler should still be kept available
• Not intended for use outside the age range confirmed by the prescribing doctor
• Caution advised if the child has phenylketonuria and the specific formulation contains aspartame — check with the pharmacist

• Phenobarbital and rifampicin may reduce blood levels of montelukast and its effectiveness
• No significant food interactions are known; the tablet may be given with or without food
• Inform the child’s doctor of all other medicines the child is taking
• Do not stop any other prescribed asthma medicine, including inhaled corticosteroids, without the doctor’s advice when starting montelukast

• Give at the same time each evening for consistency
• Confirm with the doctor or pharmacist that 4mg is the correct strength for your child’s age before each refill
• Continue treatment during symptom-free periods, as it is a preventer, not a rescue medicine
• Keep a fast-acting reliever inhaler available for sudden breathing difficulty
• Report new sleep, mood, or behaviour changes to the doctor promptly
• Store safely away from young children at all times

Hovid Montelukast 4mg Tablet is a generic montelukast product at the lowest commonly prescribed strength, intended for young children under close doctor supervision. Parents switching between montelukast brands or strengths should always confirm with the prescribing doctor or pharmacist first, as formulations and flavourings can differ even when the active ingredient dose is the same.